PRESENTER Paul Kwo, MD Professor of Medicine Medical Director, Liver Transplantation Gastroenterology/Hepatology Division Indiana University School of Medicine Indiana University Health Indianapolis, IN
ADDITIONAL CONTENT DEVELOPMENT FACULTY John F. Reinus, MD, Chair Chief of Clinical Hepatology Montefiore Medical Center Professor of Clinical Medicine Albert Einstein College of Medicine Bronx, NY
Bruce Bacon, MD James F. King MD Endowed Chair in Gastroenterology Professor of Internal Medicine Division of Gastroenterology and Hepatology Saint Louis University School of Medicine St. Louis, MO
CCME Reviewer Barry Zingman, MD Medical Director, AIDS Center Clinical Clinical Director, Infectious Diseases, Moses Division Medical Medical Director, HIV/Hepatitis C Co-Infection Program Montefiore Medical Center Professor of Clinical Medicine Albert Einstein College of Medicine Bronx, NY
AMA PRA Category 1 Credit TM Medium
THIS PROGRAM WAS ORIGINALLY PRESENTED AS A VISITING FACULTY GRAND ROUNDS SERIES THROUGHOUT THE COUNTRY, BEGINNING ON DECEMBER 3, 2014. IF YOU HAVE ALREADY RECEIVED CREDIT FOR ATTENDING ONE OF THE LIVE MEETINGS, YOU ARE INELIGIBLE TO RECEIVE CREDIT FOR THIS ENDURING ACTIVITY.
Clinicians have an opportunity to improve outcomes for patients with chronic hepatitis C virus (HCV) infection by appropriately using effective new strategies as outlined in the American Association for the Study of Liver Diseases (AASLD) practice guidelines, with the goal of helping more patients achieve sustained viral response. Education on managing the complexities of all aspects of chronic HCV infection treatment, including patient factors that can interfere with treatment and the need for improved clinician-patient communications skills, will result in improved outcomes for more patients with chronic HCV infection. Additionally, ongoing research in this area continues at a rapid pace, and clinicians must be aware of potential new agents and drug combinations for treatment of HCV so they are better prepared to incorporate them into their clinical practice. Program Developer/Facilitator
This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.
This educational activity is intended for hepatologists, infectious disease specialists, primary care and internal medicine physicians, and other clinicians interested and involved in the treatment of patients with HCV.
Upon completion of this educational activity, the participant should be able to:
Describe mechanism of action and characteristics of direct-acting antivirals.
Discuss the most current treatment guidelines for patients with HCV infection.
Review evidence for safety and efficacy of newly approved direct-acting antivirals.
Summarize safety and efficacy data on emerging interferon-free treatment regimens
The “Conflict of Interest Disclosure Policies” of Albert Einstein College of Medicine of Yeshiva University require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine of Yeshiva University (Einstein) also require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
Contributors whose COIs are irresolvable are not permitted to participate in Einstein CME activities.
Paul Kwo, MD, MPH, has disclosed the following:
Consultant: Merck, Gilead, AbbVie, Bristol-Myers Squibb, Janssen
Research Support: Merck, Gilead, AbbVie, Bristol-Myers Squibb, Janssen, Roche, Vertex
John Reinus, MD, discloses the following:
Consultant: AbbVie and Gilead.
Bruce Bacon, MD, discloses the following:
Speakers Bureau: Merck, AbbVie, Salix, Jannsen,
Research Support: Merck, Gilead Sciences, Bristol-Myers Squibb, Kadmon Pharmaceuticals, AbbVie
Advisory Board: Gilead Sciences, Bristol-Myers Squibb, Kadmon Pharmaceuticals, Janssen
Speaker: Gilead Sciences, Kadmon Pharmaceuticals
DSMB: Gilead Sciences, ISIS
Barry Zingman, MD, has nothing to disclose.
The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests relative to this CME activity.
Gena Dolson, MCM Education Senior Medical Writer, has no financial conflicts to disclose. Credit Statements
ACCME ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center, and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ACCME CREDIT DESIGNATION STATEMENT: Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support Statements
Supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Janssen Therapeutics, Division of Janssen Products, LP
There are no fees for participating in or receiving credit for this online educational activity.
Participants must view/listen to the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing education credit. Credit will be awarded for a post-test score of 80% or better, and a statement may be printed immediately after passing the post-test online.
Please turn off all pop-up blockers to ensure access to the educational activity.
Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or review your existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen. Alternatively, click on "Start as Guest."
The activity will take approximately 60 minutes to complete.
After the activity has finished, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, and MCM Education.
The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, Boehringer Ingelheim Pharmaceuticals, Inc., or Janssen Therapeutics. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.